Clinical trials
Withdrawn Peripheral Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eastern Regional Medical Center | 2 |
| CENTOGENE GmbH Rostock | 1 |
| Case Comprehensive Cancer Center | 1 |
| Conjupro Biotherapeutics, Inc. | 1 |
| Costantine Albany | 1 |
| Eurofarma Laboratorios S.A. | 1 |
| Georgetown University | 1 |
| Loma Linda University | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Nervous System Diseases | 13 |
| Breast Neoplasms | 4 |
| Diabetes Mellitus | 2 |
| Chronic Pain | 1 |
| Diabetes Complications | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Heredodegenerative Disorders, Nervous System | 1 |
| Monoclonal Gammopathy of Undetermined Significance | 1 |
| Muscle Weakness | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.